Related Experiment Video
Updated: May 31, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Treatment of risk factors to prevent stroke
1Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Okayama 701-0192, Japan. aojyun@med.kawasaki-m.ac.jp
Insights
Effective stroke prevention strategies involve managing hypertension and dyslipidemia, with ongoing research into diabetes treatment. Novel anticoagulants offer alternatives for atrial fibrillation patients, highlighting a multifaceted approach to reducing stroke incidence.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- Stroke incidence and mortality have declined due to better management of risk factors.
- Hypertension is a key modifiable risk factor, though optimal management and the role of blood pressure variability require further study.
- Diabetes poses a risk for ischemic stroke, but current glucose-lowering therapies have not proven effective for stroke prevention.
Purpose of the Study:
- To review current evidence on stroke prevention strategies.
- To discuss the role of managing hypertension, diabetes, and dyslipidemia.
- To explore emerging treatments and lifestyle modifications for stroke risk reduction.
Main Methods:
- Review of epidemiological studies and clinical trials.
- Analysis of comparative trials for antihypertensive drugs.
- Examination of evidence for statin therapy in dyslipidemia and novel anticoagulants in atrial fibrillation.
Main Results:
- Blood pressure variability may be as important as absolute blood pressure in hypertension management.
- Glycemic control trials have not demonstrated stroke prevention in diabetic patients; research on insulin resistance is ongoing.
- The SPARCL trial showed statins reduce stroke risk; dabigatran and rivaroxaban offer alternatives to vitamin K antagonists for atrial fibrillation.
Conclusions:
- Stroke prevention requires a comprehensive approach, including managing hypertension, dyslipidemia, and exploring new diabetes therapies.
- Novel anticoagulants are effective alternatives for patients with atrial fibrillation.
- Lifestyle modifications and treatment of other risk factors like metabolic syndrome and sleep-disordered breathing are crucial for stroke prevention.
Abstract:
Much of the decline in stroke incidence and mortality for the past several decades in Western countries has been attributed to better treatment of risk factors. Many epidemiological studies and clinical trials confirmed the importance of managing hypertension. Comparative trials of anti-hypertensive drugs or drug classes have not yielded clear results, but blood pressure variability may play an important role beyond the absolute value of blood pressure. Diabetes therapy remains a conundrum. Although diabetes is clearly a risk factor for ischemic stroke, treatment trials targeting different glycemic goals have not indicated that glucose lowering results in stroke prevention. Trials focused on insulin resistance are ongoing and they may be able to help establish the management of diabetes/impaired glucose tolerance. Evidence for treatment of dyslipidemia has contrasted science to diabetes mellitus. Dyslipidemia has not been strongly or consistently linked to ischemic stroke but the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial showed the impact of statin treatment in stroke prevention. The results of clinical trials investigating dabigatran and rivaroxaban clearly indicate alternative strategies to vitamin K antagonists in stroke prevention for persons with atrial fibrillation. Evidence for stroke prevention by life style modification, treating metabolic syndrome, sleep disordered breathing, lipoprotein (a), hyperhomocysteinemia, and coagulation disorders are also discussed.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Ischemic Stroke l: Introduction
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care